1. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature. 2009. 459:931–939.
2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009. 360:2605–2615.
4. Kim WJ. Novel influenza A/H1N1 pandemic: current status and prospects. J Korean Med Assoc. 2009. 52:787–794.
Article
5. Korean Center for Disease Control. Epidemiology of early detected Novel Influenza A (H1N1) in Korea, 2009. Public Health Wkly Rep. 2009. 2:689–691.
6. Lee HJ, Min SJ, Choi JW, Kang EK. Clinical characteristics of hospitalized pediatric patients with 2009 novel influenza A infection. Pediatr Allergy Respir Dis. 2010. 20:130–137.
7. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, editors. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010. 362:1708–1719.
Article
8. Falagas ME, Vouloumanou EK, Baskouta E, Rafailidis PI, Polyzos K, Rello J. Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Int J Antimicrob Agents. 2010. 35:421–430.
Article
9. Reddy D. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir. J Antimicrob Chemother. 2010. 04. 65:Suppl 2. ii35–ii40.
Article
10. de Jong MD, Simmons CP, Thanh TT, Hien VH, Smith GJ, Chau TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hyper-cytokinemia. Nat Med. 2006. 12:1203–1207.
Article
11. Eichelberger MC. The cotton rat as a model to study influenza pathogenesis and immunity. Viral Immunol. 2007. 20:243–249.
Article
12. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of self-reservation: immunopathology in influenza virus infection. Immunol Cell Biol. 2007. 85:85–92.
Article
13. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010. 50:850–859.
Article
14. Lee KY, Rhim JW, Kang JH. Hyperimmune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases. Med Hypotheses. 2011. 76:64–69.
Article
15. Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R, et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med. 2010. 36:33–41.
Article
16. Linko R, Pettila V, Ruokonen E, Varpula T, Sari Karlsson S, Tenhunen J, et al. FINN H1N1-study group. Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A (H1N1) infection in Finland. Acta Anaesthesiol Scand. (In press).
17. Confalonieri M, Cifaldi R, Dreas L, Viviani M, Biolo M, Gabrielli M. Methylprednisolone infusion for life-threatening H1N1-virus infection. Ther Adv Respir Dis. 2010. 4:233–237.
Article
18. Roberts C, Nirmalan M, O'Shea S. Steroid-sensitive post-viral inflammatory pneumonitis (PVIP). Am J Respir Crit Care Med. 2010. 182:1089–1090.
Article
19. Kil HR, Lee JH, Lee KY, Rhim JW, Youn YS, Kang JH. Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus. Critical Care. 2011. 15:413.
Article
20. Annane D. Pro: The illegitimate crusade against corticosteroids for severe H1N1 pneumonia. Am J Respir Crit Care Med. 2011. 183:1125–1126.
Article
21. Rhim JW, Lee KY, Youn YS, Kang JH, Kim JC. Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: An observational cohort study. BMC infect Dis. 2011. 11:225.
Article
22. Bettinger JA, Sauvé LJ, Scheifele DW, Moore D, Vaudry W, Tran D, et al. Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine. 2010. 28:3180–3184.
Article
23. Matthay MA, Lia KD. Con: Corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia. Am J Respir Crit Care Med. 2011. 183:1127–1128.
Article
24. Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med. 2011. 183:1207–1214.
Article
25. Brun-Buisson C, Richard JC, Mercat A, Thiébaut A, Brochard L. Early corticosteroids in severe Influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2011. 183:1200–1206.
Article
26. Witkop CT, Duffy MR, Macias EA, Gibbons TF, Escobar JD, Burwell KN, et al. Novel influenza A (H1N1) outbreak at the US Air Force Academy: epidemiology and viral shedding duration. Am J Prev Med. 2010. 38:121–126.
27. Confalonieri M, D'Agaro P, Campello C. Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. Intensive Care Med. 2010. 36:1780–1781.
Article
28. Aviram G, Bar-Shai A, Sosna J, Rogowski O, Rosen G, Weinstein I, et al. H1N1 influenza: initial chest radiographic findings in helping predict patient outcome. Radiology. 2010. 255:252–259.
Article
29. Choi SH, Kang EY, Kim JS, Kim YK. Radiologic review of an outbreak of the pandemic (H1N1) 2009 Virus Infection at a university hospital in Seoul, Korea. J Korean Soc Radiol. 2011. 64:341–350.
Article
30. Korppi M, Don M, Valent F, Calciani M. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children. Acta Paediatr. 2008. 97:943–947.
Article
31. World Health Organization. Human infection with new influenza A (H1N1) virus: Clinical observations from a school associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec. 2009. 84:237–244.
32. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009. 361:1935–1944.
Article
33. Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systemic review and meta-analysis. Crit Care Med. 2009. 37:1594–1603.
Article